Editorial – Thiolated Chitosan-carboxymethyl Dextran Nanoparticles: Improving Intravitreal Drug Bioavailability for Retinoblastoma


This is an Editorial. Please download the PDF or view the article HTML.


Not applicable

1. Delrish E, Ghasemi F, Jabbarvand M, Lashay A, Atyabi F, Soleimani M, et al. Biodistribution of Cy5-labeled Thiolated and Methylated Chitosan-Carboxymethyl Dextran Nanoparticles in an Animal Model of Retinoblastoma. J Opthalmic Vis Res 2022;17:58–68.

2. Broaddus E, Topham A, Singh AD. Incidence of retinoblastoma in the USA: 1975–2004. Br J Ophthalmol 2009;93:21–23.

3. Stacey AW, Bowman R, Foster A, Kivelä TT, Munier FL, Cassoux N, et al. Incidence of retinoblastoma has increased: results from 40 European countries. Ophthalmology 2021;128:1369–1371.

4. Fabian ID, Abdallah E, Abdullahi SU, Abdulqader RA, Boubacar SA, Ademola-Popoola DS, et al. Global retinoblastoma presentation and analysis by national income level. JAMA Oncol 2020;6:685–695.

5. Dalvin LA, Kumari M, Essuman VA, Shipa SS, Ancona- Lezama D, Lucio-Alvarez JA, et al. Primary intra-arterial chemotherapy for retinoblastoma in the intravitreal chemotherapy era: five years of experience. Ocul Oncol Pathol 2019;5:139–146.

6. Agrahari V, Mandal A, Agrahari V, Trinh HM, Joseph M, Ray A, et al. A comprehensive insight on ocular pharmacokinetics. Drug Deliv Transl Res 2016;6:735–754.

7. Willekens K, Reyns G, Diricx M, Vanhove M, Noppen B, Coudyzer W, et al. Intravitreally injected fluid dispersion: importance of injection technique. Invest Ophthalmol Vis Sci 2017;58:1434–1441.

8. Bonfiglio A, Repetto R, Siggers JH, Stocchino A. Investigation of the motion of a viscous fluid in the vitreous cavity induced by eye rotations and implications for drug delivery. Phys Med Biol 2013;58:1969–1982.

9. Modareszadeh A, Abouali O, Ghaffarieh A, Ahmadi G. Saccade movements effect on the intravitreal drug delivery in vitreous substitutes: a numerical study. Biomech Model Mechanobiol 2013;12:281–290.

10. Buitrago E, Winter U, Williams G, Asprea M, Chantada G, Schaiquevich P. Pharmacokinetics of melphalan after intravitreal injection in a rabbit model. J Ocul Pharmacol Ther 2016;32:230–235.

11. Ilochonwu BC, Urtti A, Hennink WE, Vermonden T. Intravitreal hydrogels for sustained release of therapeutic proteins. J Control Release 2020;326:419–441.

12. Mohammed MA, Syeda JTM, Wasan KM, Wasan EK. An overview of chitosan nanoparticles and its application in non-parenteral drug delivery. Pharmaceutics 2017;9: 53.

13. Zamboulis A, Nanaki S, Michailidou G, Koumentakou I, Lazaridou M, Ainali NM, et al. Chitosan and its derivatives for ocular delivery formulations: recent advances and developments. Polymers 2020;12:1519.

14. Liu D, Li J, Pan H, He F, Liu Z, Wu Q, et al. Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin. Sci Rep 2016;6: 28796.

15. Bernkop-Schnürch A, Hornof M, Guggi D. Thiolated chitosans. Eur J Pharm Biopharm 2004;57:9–17.

16. Gilbert RE, Cox AJ, Kelly DJ, Wilkinson-Berka JL, Sage EH, Jerums G, et al. Localization of secreted protein acidic and rich in cysteine (SPARC) expression in the rat eye. Connect Tissue Res 1999;40:295–303.

17. Koo H, Moon H, Han H, Na JH, Huh MS, Park JH, et al. The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection. Biomaterials 2012;33:3485–3493.

18. Delrish E, Jabbarvand M, Ghassemi F, Amoli FA, Atyabi F, Lashay A, et al. Efficacy of topotecan nanoparticles for intravitreal chemotherapy of retinoblastoma. Exp Eye Res 2021;204:108423.